Nasdaq Issues Delisting Notice to Oriental Rise Holdings Following Bid Price Non-Compliance and Failed Reverse Stock Split

summarizeSummary

Oriental Rise Holdings received a Nasdaq delisting notice due to bid price non-compliance, exacerbated by a failed reverse stock split and severe financial deterioration, including negative operating cash flow and internal control weaknesses.

check_boxKey Events

• Nasdaq Delisting Notice Received

  The company received a staff determination letter on April 15, 2026, from Nasdaq, indicating non-compliance with the $1.00 bid price rule (Rule 5550(a)(2)). Due to a prior 1-for-20 reverse stock split on December 30, 2025, the company is not eligible for the standard 180-day compliance period. Nasdaq has scheduled a delisting, which the company has appealed, with a hearing set for May 19, 2026.

• Significant Financial Deterioration

  Revenue decreased to $12.2 million in FY2025 (down 18.6% year-over-year from $15.0 million in FY2024), and net profit fell to $0.68 million (down 67.4% year-over-year from $2.09 million in FY2024). Gross profit margin plummeted from 53.0% in FY2023 to 10.8% in FY2025. Cash flow from operations turned negative, reporting $(0.58) million in FY2025, compared to positive cash flow in prior years.

• Material Weaknesses in Internal Controls

  Management concluded that disclosure controls and procedures were ineffective as of December 31, 2025. Identified deficiencies include a lack of review procedures within financial reporting, absence of a formal impairment assessment process for long-lived assets, insufficient U.S. GAAP/SEC accounting personnel, and inadequate monitoring of related party transactions.

• Dilutive Private Placement and Warrant Exercise

  On July 23, 2025, the company completed a private placement of 14.8 million units (each consisting of one ordinary share and one warrant) at $0.4681 per unit, raising approximately $6.9 million gross. The warrants included downward pricing adjustment mechanisms and were fully exercised by August 8, 2025, resulting in the issuance of 47,323,247 ordinary shares.

auto_awesomeAnalysis

Oriental Rise Holdings faces imminent delisting from Nasdaq after failing to regain compliance with the $1.00 bid price rule, despite a 1-for-20 reverse stock split in December 2025. The company's financial performance has severely deteriorated, with significant declines in revenue, net profit, and gross margins, alongside negative cash flow from operations in 2025. Furthermore, management identified material weaknesses in internal controls over financial reporting, raising concerns about financial transparency and reliability. The company has appealed the delisting decision, with a hearing scheduled for May 19, 2026.